View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . September 7th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Cardiovascular Disease - Resverlogix Phase 1b/2a Study Meets Primary Endpoint

Multiple Sclerosis - Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009

RegeneRx Biopharmaceuticals, Inc. - RegeneRx Receives Notice of Allowance in Europe for Key Patent Related to Inhibition and Reversal of Skin Aging

Surgery - ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%

Alzheimer Disease - Reports outline Alzheimer disease study results from B.P. Imbimbo et al

Circadian Rhythm Sleep Disorders - Research from University of Gottingen yields new findings on circadian rhythm sleep disorders

Drug Resistance - Study findings on drug resistance are outlined in reports from A. Wright and colleagues

Immunization - Study data from K. Miura et al provide new insights into immunization

Life Sciences - Research in the area of life sciences reported from Technical University of Munich

Mesothelioma - Data on mesothelioma described by researchers at Brigham and Women's Hospital

Peripheral Nervous System Disease - Report summarizes peripheral nervous system disease study findings from C. Noto and co-researchers

Prostate Cancer - New prostate cancer research from University of Birmingham described

Rehabilitation Research - New rehabilitation research research from A.W. Dromerick and colleagues discussed

Antisense Technology - Data on antisense technology reported by researchers at University Hospital

Cancer Therapy - Research from Memorial Sloan Kettering Cancer Center, Department of Surgery in the area of cancer therapy published

Cancer Vaccines - Researchers from University of Yamanashi, First Department of Surgery describe findings in cancer vaccines

Pharmacokinetics - Research findings from General Hospital, Medical Department update understanding of pharmacokinetics

Solid Cancer - Research on solid cancer described by scientists at National Cancer Center Hospital, Division of Internal Medicine

Alvine Pharmaceuticals, Inc. - Alvine Initiates Enrollment in Phase 2a Clinical Trial of ALV003 for Use in the Treatment of Celiac Disease

Cancer - PCI Biotech Commences Phase I/II Trials of Amphinex(R)

Cardiology - NewCardio Announces Master Services Agreement With Top-Three Contract Research Organization

Clinical Trial Research - R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021

Coagulation - Regado Biosciences Announces First Patient Enrolled In Phase 1 Study of Subcutaneously Administered Reg1 Anticoagulation System

Drug Development - Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study

Dyax Corp. - Dyax Announces Developments in Licensing and Funded Research Program

Endocyte, Inc. - Endocyte Says Collaboration Paying Off

Geneuity - Geneuity Releases Biomarker Assays for Early Detection of Kidney Damage

Leishmaniasis - IDRI Initiates Therapeutic Vaccine Clinical Trial in Sudan Against Leishmaniasis

Neuralgia - Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)

Novelos Therapeutics, Inc. - Novelos Therapeutics Announces $9 Million Private Placement

Protein Therapies - Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU-016

Resolvyx Pharmaceuticals, Inc. - Resolvyx Announces Positive Data from Phase 2 Clinical Trial of the Resolvin RX-10045 in Patients with Dry Eye Syndrome

Schizophrenia - Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study

Tikcro Technologies - US Department of Health and Human Services Grants Orphan Drug Status to BioCancell's Ovarian Cancer Drug

Type 2 Diabetes - Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx